City View Green Holdings Inc. (CVGR.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 705.7 Thousand CAD | -70.25% |
| 2022 | 2.37 Million CAD | -6.55% |
| 2021 | 2.53 Million CAD | -52.33% |
| 2020 | 5.32 Million CAD | 22.97% |
| 2019 | 4.33 Million CAD | 352.41% |
| 2018 | 957.24 Thousand CAD | 200.76% |
| 2017 | 318.27 Thousand CAD | 164.35% |
| 2016 | 120.39 Thousand CAD | -0.03% |
| 2015 | 120.43 Thousand CAD | -31.39% |
| 2014 | 175.54 Thousand CAD | -55.37% |
| 2013 | 393.36 Thousand CAD | -65.3% |
| 2012 | 1.13 Million CAD | -39.03% |
| 2011 | 1.85 Million CAD | -5.02% |
| 2010 | 1.95 Million CAD | 83.99% |
| 2009 | 1.06 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 155.64 Thousand CAD | -2.42% |
| 2024 Q2 | 219.62 Thousand CAD | 41.11% |
| 2023 Q2 | 240.49 Thousand CAD | -4.62% |
| 2023 Q4 | 159.49 Thousand CAD | -42.64% |
| 2023 FY | 705.7 Thousand CAD | -70.25% |
| 2023 Q1 | 252.14 Thousand CAD | -57.06% |
| 2023 Q3 | 278.05 Thousand CAD | 15.62% |
| 2022 FY | 2.37 Million CAD | -6.55% |
| 2022 Q4 | 587.16 Thousand CAD | -4.73% |
| 2022 Q3 | 616.34 Thousand CAD | -0.75% |
| 2022 Q2 | 621.02 Thousand CAD | 10.73% |
| 2022 Q1 | 560.86 Thousand CAD | -51.68% |
| 2021 Q2 | 505.22 Thousand CAD | 35.0% |
| 2021 Q4 | 1.16 Million CAD | 132.91% |
| 2021 Q1 | 374.23 Thousand CAD | -84.22% |
| 2021 FY | 2.53 Million CAD | -52.33% |
| 2021 Q3 | 498.32 Thousand CAD | -1.37% |
| 2020 Q1 | 404.82 Thousand CAD | -65.83% |
| 2020 FY | 5.32 Million CAD | 22.97% |
| 2020 Q2 | 689.25 Thousand CAD | 70.26% |
| 2020 Q3 | 1.85 Million CAD | 169.86% |
| 2020 Q4 | 2.37 Million CAD | 27.5% |
| 2019 Q2 | 1.47 Million CAD | 80.36% |
| 2019 Q3 | 850.31 Thousand CAD | -42.42% |
| 2019 Q4 | 1.18 Million CAD | 39.34% |
| 2019 FY | 4.33 Million CAD | 352.41% |
| 2019 Q1 | 818.78 Thousand CAD | 580.11% |
| 2018 Q1 | 641.69 Thousand CAD | 410.37% |
| 2018 Q2 | 115.17 Thousand CAD | -82.05% |
| 2018 Q4 | 120.39 Thousand CAD | 50.52% |
| 2018 FY | 957.24 Thousand CAD | 200.76% |
| 2018 Q3 | 79.98 Thousand CAD | -30.55% |
| 2017 Q3 | 72.19 Thousand CAD | 39.37% |
| 2017 Q2 | 51.8 Thousand CAD | -24.43% |
| 2017 Q1 | 68.54 Thousand CAD | -2.25% |
| 2017 FY | 318.27 Thousand CAD | 164.35% |
| 2017 Q4 | 125.73 Thousand CAD | 74.15% |
| 2016 FY | 120.39 Thousand CAD | -0.03% |
| 2016 Q3 | 15.65 Thousand CAD | -10.52% |
| 2016 Q1 | 17.12 Thousand CAD | -7.77% |
| 2016 Q4 | 70.12 Thousand CAD | 347.88% |
| 2016 Q2 | 17.49 Thousand CAD | 2.2% |
| 2015 Q3 | 31.27 Thousand CAD | 51.83% |
| 2015 Q4 | 18.56 Thousand CAD | -40.64% |
| 2015 FY | 120.43 Thousand CAD | -31.39% |
| 2015 Q2 | 20.59 Thousand CAD | -58.81% |
| 2015 Q1 | 50 Thousand CAD | 12.37% |
| 2014 Q4 | 44.5 Thousand CAD | 14.62% |
| 2014 Q3 | 38.82 Thousand CAD | -20.73% |
| 2014 FY | 175.54 Thousand CAD | -55.37% |
| 2014 Q1 | 43.23 Thousand CAD | 9.27% |
| 2014 Q2 | 48.97 Thousand CAD | 13.28% |
| 2013 Q3 | 77.06 Thousand CAD | -35.85% |
| 2013 Q4 | 39.56 Thousand CAD | -48.66% |
| 2013 FY | 393.36 Thousand CAD | -65.3% |
| 2013 Q1 | 156.59 Thousand CAD | -49.02% |
| 2013 Q2 | 120.12 Thousand CAD | -23.29% |
| 2012 Q4 | 307.18 Thousand CAD | 24.21% |
| 2012 Q2 | 304.32 Thousand CAD | 10.73% |
| 2012 Q1 | 274.82 Thousand CAD | 54.49% |
| 2012 Q3 | 247.3 Thousand CAD | -18.74% |
| 2012 FY | 1.13 Million CAD | -39.03% |
| 2011 Q3 | 386.77 Thousand CAD | -60.8% |
| 2011 Q1 | 308.25 Thousand CAD | -33.52% |
| 2011 Q4 | 177.89 Thousand CAD | -54.0% |
| 2011 Q2 | 986.58 Thousand CAD | 220.05% |
| 2011 FY | 1.85 Million CAD | -5.02% |
| 2010 Q2 | 493.15 Thousand CAD | 15.34% |
| 2010 Q3 | 573.44 Thousand CAD | 16.28% |
| 2010 FY | 1.95 Million CAD | 83.99% |
| 2010 Q4 | 463.7 Thousand CAD | -19.14% |
| 2010 Q1 | 427.57 Thousand CAD | 0.0% |
| 2009 FY | 1.06 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aion Therapeutic Inc. | 163.11 Thousand CAD | -332.64% |
| Ayurcann Holdings Corp. | 11.71 Million CAD | 93.977% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -737.885% |
| The BC Bud Corporation | 1.28 Million CAD | 44.995% |
| BioNxt Solutions Inc. | 6.73 Million CAD | 89.529% |
| CordovaCann Corp. | 3.86 Million CAD | 81.725% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | 83.524% |
| Captor Capital Corp. | 16.28 Million CAD | 95.666% |
| 1CM Inc. | 7.3 Million CAD | 90.343% |
| Global Hemp Group Inc. | 551.7 Thousand CAD | -27.913% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | 85.321% |
| IM Cannabis Corp. | 22.63 Million CAD | 96.883% |
| Lobe Sciences Ltd. | 4.13 Million CAD | 82.922% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | -79.929% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -1076.182% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | 60.085% |
| Ovation Science Inc. | 54.1 Thousand CAD | -1204.453% |
| Pharmadrug Inc. | 1.33 Million CAD | 47.138% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | 45.94% |
| RAMM Pharma Corp. | 7.48 Million CAD | 90.566% |
| RIV Capital Inc. | 21.1 Million CAD | 96.656% |
| Revive Therapeutics Ltd. | 3.28 Million CAD | 78.522% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | 98.131% |
| SLANG Worldwide Inc. | 24.6 Million CAD | 97.132% |
| 1933 Industries Inc. | 5.12 Million CAD | 86.231% |
| Red Light Holland Corp. | 2.02 Million CAD | 65.072% |
| Top Strike Resources Corp. | 3.63 Million CAD | 80.568% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 328.813% |
| Adastra Holdings Ltd. | 9.36 Million CAD | 92.461% |